Establishment Labs Holdings (ESTA) Cash & Equivalents Growth (3y) (2025)
Establishment Labs Holdings (ESTA) Cash & Equivalents Growth (3y) (2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.33 Bn | 193.73 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 73.11 Bn | 72.58 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 52.09 Bn | 47.84 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.43 Bn | 32.48 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.05 Bn | 22.57 Bn | 684.20 Mn | 32.23% |
| 10 | Establishment Labs Holdings | 2.15 Bn | 2.08 Bn | 47.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.43% |